Does ABATACEPT Cause Hepatic steatosis? 345 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 345 reports of Hepatic steatosis have been filed in association with ABATACEPT (ORENCIA). This represents 0.3% of all adverse event reports for ABATACEPT.
345
Reports of Hepatic steatosis with ABATACEPT
0.3%
of all ABATACEPT reports
2
Deaths
109
Hospitalizations
How Dangerous Is Hepatic steatosis From ABATACEPT?
Of the 345 reports, 2 (0.6%) resulted in death, 109 (31.6%) required hospitalization, and 6 (1.7%) were considered life-threatening.
Is Hepatic steatosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABATACEPT. However, 345 reports have been filed with the FAERS database.
What Other Side Effects Does ABATACEPT Cause?
Drug ineffective (35,212)
Rheumatoid arthritis (21,898)
Pain (19,783)
Arthralgia (18,536)
Joint swelling (18,453)
Contraindicated product administered (13,559)
Fatigue (13,087)
Drug intolerance (12,451)
Rash (12,168)
Arthropathy (11,099)
What Other Drugs Cause Hepatic steatosis?
METHOTREXATE (1,400)
ADALIMUMAB (1,058)
ETANERCEPT (620)
TOCILIZUMAB (476)
TOFACITINIB (405)
LEFLUNOMIDE (359)
HYDROXYCHLOROQUINE (358)
METFORMIN (343)
INFLIXIMAB (325)
SECUKINUMAB (308)
Which ABATACEPT Alternatives Have Lower Hepatic steatosis Risk?
ABATACEPT vs ABATACEPT SUBQ /ML
ABATACEPT vs ABCIXIMAB
ABATACEPT vs ABEMACICLIB
ABATACEPT vs ABILIFY
ABATACEPT vs ABIRATERONE